
|Videos|July 27, 2022
Dr. Alexis Rompré-Brodeur on germline testing in renal cell carcinoma
Author(s)Urology Times staff
Advertisement
Alexis Rompré-Brodeur, MD, a urologic oncologist at McGill University discusses germline testing in patients with renal cell carcinoma. Rompré-Brodeur presented the study, “Germline testing in renal cell carcinoma: can enrichment features help predict germline alterations?” at the 2022 AUA Annual Meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA receives NDA submission for UGN-103 in recurrent LG-IR-NMIBC
2
Radium-223 fails to improve skeletal event-free survival in metastatic RCC
3
HoLEP learning curve and strategies for successful adoption, with Daniel S. Kellner, MD
4
Active surveillance use for low-risk prostate cancer reaches 93% in VA System
5











